|
Model Number MMT-105ELBLNA |
Device Problems
Insufficient Flow or Under Infusion (2182); Connection Problem (2900); Patient Device Interaction Problem (4001)
|
Patient Problem
Insufficient Information (4580)
|
Event Date 06/06/2022 |
Event Type
malfunction
|
Event Description
|
Information received by medtronic indicated that the inpen was not delivering.Customer stated screw was not moving as intended.Customer stated that no insulin was dispensed when the button was pushed.Customer stated that no insulin exist with initial prime.Customer reported that does dial was misaligned.No harm requiring medical intervention was reported.The customer will discontinue use of the device.
|
|
Manufacturer Narrative
|
Customer reports: leadscrew is not moving as intended, dose dial is misaligned and cartridge holder is broken.Per visual inspection: no physical damage to cap, cartridge holder or inpen was noted.The alignment of the dose indicator mark and printed values on the dose knob is nominal.No misalignment of the dial was noted.The inpen paired to the commercial app with small pairing dose.Received inpen 1/4 of travel.Unable to re-wind inpen.The leadscrew does unexpectedly retracts into the inpen while dialing doses.Unable to perform functional test due to leadscrew retracting anomaly.Pending further analysis that will be performed at san diego location.Medtronic, inc.(medtronic) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information in the time allotted and has provided as much information as is available to the company as of the submission date this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects" or has "malfunctioned".These words are included in the fda 3500a form and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.Medtronic objects to the use of these words and others like it because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Manufacturer Narrative
|
Per visual inspection: no physical damage to cap, cartridge holder or inpen was noted.The alignment of the dose indicator mark and printed values on the dose knob is nominal.No misalignment of the dial was noted.The inpen paired to the commercial app with small pairing dose.Received inpen 1/4 of travel.Unable to re-wind inpen.The leadscrew does unexpectedly retracts into the inpen while dialing doses.Unable to perform functional test due to leadscrew retracting anomaly.In conclusion: per dennis berg san diego investigation: leadscrew anomaly was caused by debris was lodged between the dose dial and the electronics housing causing it to retract and extend when dialing a dose.Therefore, the customer complaint of leadscrew anomaly was confirmed due to dust/debris.However, no physical damage was noted on cartridge holder and dose dial is not misaligned.Therefore the customers complaint of cartridge holder being broken and dose dial is misaligned was not confirmed.Medtronic, inc.(medtronic) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information in the time allotted and has provided as much information as is available to the company as of the submission date this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects" or has "malfunctioned".These words are included in the fda 3500a form and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.Medtronic objects to the use of these words and others like it because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Search Alerts/Recalls
|
|
|